Prof. dr. G.M.J. Bos

Internist-Hematoloog

Aandachtsgebieden

  • M. Myeloma
  • Preclinical and clinical research on immunotherapy
  • Medical education: vice-chair board of examinors, FHML, medical school.

BIG-register

89020172501

Contact

Over

After Medical School and a PhD program on immunology (both at the medical school in Maastricht) Gerard Bos started training in internal medicine in Maastricht for two years. He moved to The Hague to a non-university Hospital to obtain clinical experience outside the university system. After training for internal medicine he was trained as a Haematologist again in University and non-University hospitals. After registration as a haematologist (1995) he stayed in the Daniel den Hoed Cancer Centre for three years as clinical fellow, especially to obtain more clinical experience. Thereafter he obtained a fellowship (Clinical Research Award by the Dutch Cancer Foundation)  to perform a two year research program on tumor-immunology (Leiden, Brussels and Utrecht). He started in Maastricht 2000, as internist-haematologist. 

  • Since 2020 he is not active any more in direct clinical practice. 
  • (Pre-)clinical research has a focus on cell therapy: development of cancer vaccines and the role of natural killer cells in the fight against cancer. This included various types of donor bone marrow transplantation.
  • Two other topics of research: patient involvement in clinical care and cost-effectivity of clinical interventions. 
  • In 2013 he was appointed as professor on medical education and tumor-immunology, now focusing on tumor-immunology only.
  • Since 2005 he is CEO of CiMaas, a start-up company from MUMC+ focusing om cell therapy in cancer. 
  • Since 2020 he is chair of the board of Studium Generale (University Maastricht).
Sluit de enquête
Geef uw mening over de website, of vertel ons hoe wij onze website kunnen verbeteren.
De volgende links voor privacy en servicevoorwaarden behoren tot de reCAPTCHA-plugin van Google.